Gisa Gerold is a researcher at the Institute of Virology, Medical University of Innsbruck in Austria. Dr. Gerold's research integrates mass spectrometry-based proteomics and CRISPR-based gene editing to identify and characterize host factors, such as human CD81, that are essential for the replication of arthritogenic alphaviruses like Chikungunya virus (CHIKV).